Skip to main content

Table 1 Laboratory findings of the patient.

From: Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis

 

2001

2006

  

During inflammatory

calcinosis

Before thalidomide

(inacitive phase)

3 months

12 months

WBC (μL)

27,300

7,100

6,400

5,200

Hb (g/dL)

11.6

11.3

9.5

12.7

Platelets (×104/μL)

24.7

24.6

35.7

35.7

ESR (mm/h)

27

17

3

4

FDP-E (ng/mL)

225

237

95

85

AST (U/L)

20

   

ALT (U/L)

7

   

LDH (U/L)

271

   

CRP (mg/dL)

21.0

0.2

0.1

0.4

Triglycerides (mg/dL)

nd

251

74

93

Total cholesterol (mg/dL)

nd

121

145

156

IgG (mg/dL)

nd

2,056

813

916

  1. The levels of FDP-E, IgG, and triglycerides were all elevated before thalidomide gradually reduced them to the normal range.